Cargando…

Impaired Fibrinolytic Potential Predicts Oxygen Requirement in COVID-19

Abnormal coagulation and fibrinolysis contributes to the respiratory distress syndrome in COVID-19. We aimed to explore the association of impaired fibrinolytic potential with disease severity and oxygen requirement in hospitalized patients. Adults admitted to hospital with confirmed COVID-19 infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Julie, Choy, Kay Weng, Lim, Hui Yin, Ho, Prahlad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605464/ https://www.ncbi.nlm.nih.gov/pubmed/36294850 http://dx.doi.org/10.3390/jpm12101711

Ejemplares similares

Laboratory markers of severity across three COVID-19 outbreaks in Australia: has Omicron and vaccinations changed disease presentation?
por: Wang, Julie, et al.
Publicado: (2022)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)

IMPAIRED ENDOGENOUS FIBRINOLYTIC CAPACITY IN PREHYPERTENSIVE MEN
por: Diehl, Kyle J., et al.
Publicado: (2015)

Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
por: Nielsen, Nathan D., et al.
Publicado: (2022)

The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19
por: Onishi, Tomoko, et al.
Publicado: (2022)

The Prothrombotic Tendency in Metabolic Syndrome: Focus on the Potential Mechanisms Involved in Impaired Haemostasis and Fibrinolytic Balance
por: Russo, Isabella
Publicado: (2012)

Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
por: Lim, Hui Yin, et al.
Publicado: (2022)

Fibrinolytic therapy for COVID-19: a review of case series
por: Ji, Hong-Long, et al.
Publicado: (2021)

Potential fibrinolytic activity of an endophytic Lasiodiplodia pseudotheobromae species
por: Meshram, Vineet, et al.
Publicado: (2016)

Assessing plasminogen activation potential with global fibrinolytic assays
por: Urano, Tetsumei, et al.
Publicado: (2019)

Fibrinolytic potential as a risk factor for postpartum hemorrhage
por: Gruneberg, Daniel, et al.
Publicado: (2023)

Association of Fibrinolytic Potential and Risk of Mortality in Cancer Patients
por: Gois, Gabriele Silva Souza, et al.
Publicado: (2023)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
por: Kwaan, Hau C., et al.
Publicado: (2021)

The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
por: Whyte, Claire S., et al.
Publicado: (2022)

Desialylated endothelial cells membrane enhance its fibrinolytic potential
por: Zouaoui Boudjeltia, K, et al.
Publicado: (2006)

Erratum to: Potential fibrinolytic activity of an endophytic Lasiodiplodia pseudotheobromae species
por: Meshram, Vineet, et al.
Publicado: (2016)

Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis
por: McLeod, Blake, et al.
Publicado: (2022)

THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI
por: Tillett, William S., et al.
Publicado: (1933)

Fibrinolytic Therapy in Acute Stroke
por: Millán, Mònica, et al.
Publicado: (2010)

Therapeutics targeting the fibrinolytic system
por: Lin, Haili, et al.
Publicado: (2020)

The Fibrinolytic System: Mysteries and Opportunities
por: Medcalf, Robert L., et al.
Publicado: (2021)

Fibrinolytic Changes in Women with Preeclampsia
por: Godtfredsen, Anne Cathrine, et al.
Publicado: (2022)

Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
por: Wang, Julie, et al.
Publicado: (2022)

Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era
por: Elbadawi, Ayman, et al.
Publicado: (2020)

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
por: Yamada, Shinya, et al.
Publicado: (2022)

Commentary on “The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1”
por: von Meijenfeldt, Fien A.
Publicado: (2022)

Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport
por: Fu, Yunmei, et al.
Publicado: (2023)

Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic
por: Choy, Kay Weng
Publicado: (2020)

A case of hemothorax secondary to intrapleural fibrinolytic therapy: Considerations for use of fibrinolytics in high-risk patients
por: Narula, Naureen, et al.
Publicado: (2021)

Research progress on the fibrinolytic enzymes produced from traditional fermented foods
por: Wang, Panpan, et al.
Publicado: (2023)

Total Hip Arthroplasty Patients with Distinct Postoperative Fibrinolytic Phenotypes Require Different Antifibrinolytic Strategies
por: Liu, Jiacheng, et al.
Publicado: (2022)

Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi
por: Whyte, Claire S., et al.
Publicado: (2021)

Fibrinolytic or anti-plasmin (nafamostat) therapy for COVID-19: A timing challenge for clinicians
por: Ji, Hong-Long, et al.
Publicado: (2021)

Fibrinolytic and coagulative activities of Yersinia pestis
por: Korhonen, Timo K., et al.
Publicado: (2013)

The Role of Fibrinolytic System in Health and Disease
por: Kwaan, Hau C.
Publicado: (2022)

Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population
por: Lim, Hui Yin, et al.
Publicado: (2016)

Dabigatran Toxicity in Acute Kidney Injury: Hemodialysis and Idarucizumab Required
por: McBride, Lucy, et al.
Publicado: (2018)

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial
por: Schol‐Gelok, Suzanne, et al.
Publicado: (2020)

Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
por: Barrett, Christopher D., et al.
Publicado: (2020)

Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients
por: Marchetti, Marina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sacafr9edd4d10tk2bso3hva4a